Regenexx® Stem Cell Treatments are the world’s most advanced, non-surgical orthopedic stem cell therapies for common joint injuries and degenerative conditions, such as osteoarthritis and avascular necrosis. These patented, next-generation stem cell injection procedures utilize an individual’s own bone-marrow derived stem cells and blood platelet rich plasma mixtures to amplify the body’s ability to heal damaged tissues, tendons, ligaments, cartilage, spinal disc, or bone.
Regenexx Stem Cell and Blood Platelet Procedures offer a viable alternative for individuals suffering from joint pain, or who may be considering elective surgery or joint replacement due to injury or arthritis. Patients avoid the lengthy periods of downtime and painful rehabilitation that follow invasive surgeries.
Commonly Treated Conditions - Regenexx Stem Cell Therapy and Platelet Rich Plasma Procedures
The list below represents the most commonly treated conditions using Regenexx stem cell therapy or platelet procedures. It is not a complete list, so please contact us or complete the Regenexx Candidate Form if you have questions about whether you or your condition can be treated with these non-surgical procedures. The type of procedure used (stem cell or blood platelet) to treat these conditions is largely dependent upon the severity of the injury or condition.
- Rotator cuff tears
- Arthritis of the shoulder joint
- Thoracic outlet syndrome
- Labral tears or degeneration
- Rotator cuff tendonitis
- AC Joint Separation
- Recurrent shoulder dislocations
- Patellofemoral Syndrome/Chondomalacia
- Pes anersine bursitis
- Baker’s cyst
- Patellar tendonitis
- Meniscus tear
- MCL sprain or tear
- ACL sprain or tear
- PCL sprain or tear
- LCL sprain or tear
- Biceps Femoris Insertional Tendinopathy
- Hamstrings Tendinopathy
- Ankle Instability
- Peroneal tendon tear or split
- Ligament sprain or tear
- Sub-talar arthritis or instability
- Tarsal tunnel syndrome
- Plantar fasciitis
23,080 Regenexx procedures have been performed since Regenexx pioneered orthopedic stem cell treatments in 2005
The published research on Regenexx procedures accounts for approx. 33% of the world’s orthopedic stem cell literature (cumulative n of patients published and treated with bone marrow stem cells)
Regenexx® Patented Orthopedic Stem Cell Therapy Televised to Millions Across U.S.
As our Regenexx Physician Network grows, so does the nationwide awareness of our next-generation regenerative stem cell injection procedures. This video selection is comprised of recent local news stories, media coverage and hit television show appearances, featuring Regenexx doctors and patients from around the network, sharing their stories. For more Regenexx videos, please visit our videos page or YouTube Channel.